文献速递妇科生殖医学

多囊卵巢综合征与体重指数升高独立增加2型糖尿病风险且肥胖介导的风险占主导:美国患者真实世界数据分析

Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.
PubMed 文献 · Fertil Steril · 2025-09-12

基于美国IBM Explorys数据库的纵向病例对照研究,纳入2000至2020年诊断的多囊卵巢综合征(PCOS)女性42030例及按种族、地区、年龄和体重指数(BMI)1:2匹配的无PCOS对照84060例。PCOS组3年和15年2型糖尿病累积发病率分别为9.2%和34.3%,均高于对照组的6.0%和22.6%;校正后风险比(HR)为1.47,且在各BMI分层中一致。PCOS患者BMI升高带来的额外2型糖尿病风险(HR 1.87)超过PCOS本身通过其他机制带来的风险。

要点

  • PCOS女性3年2型糖尿病累积发病率为9.2%,15年为34.3%,均高于无PCOS对照。
  • 校正混杂因素后,PCOS与2型糖尿病风险升高独立相关(HR 1.47,95%CI 1.41-1.53)。
  • PCOS患者BMI中位数34.86 kg/m2,较未匹配BMI的对照高7.6 kg/m2,该差异额外增加2型糖尿病风险(HR 1.87)。

核心结论

  • 在本分析中,PCOS在所有BMI类别中均与2型糖尿病发病率升高独立相关。
  • PCOS患者BMI升高通过过多脂肪组织介导额外的2型糖尿病风险,该风险超过PCOS通过高雄激素血症等其他机制带来的风险。

研究设计与样本

  • 研究为纵向病例对照研究,使用美国IBM Explorys数据库,该数据库包含来自美国约400家医院去标识化的纵向患者电子健康记录。
  • 研究人群为2000至2020年间诊断为PCOS、年龄25至55岁的女性(n=42,030)及无PCOS对照女性(n=84,060),按种族、地理区域、年龄和BMI以1:2匹配。
  • 另设二次对照组(n=42,030),除BMI外所有协变量均匹配。
  • PCOS状态通过国际疾病分类编码诊断识别,2型糖尿病诊断通过国际疾病分类编码及糖化血红蛋白水平确定。

主要发现

  • PCOS组与无PCOS组的3年2型糖尿病累积发病率分别为9.2%(95%CI 8.9%-9.5%)和6.0%(95%CI 5.8%-6.2%)。
  • PCOS组与无PCOS组的15年2型糖尿病累积发病率分别为34.3%(95%CI 31.4%-37.4%)和22.6%(95%CI 21.2%-24.1%)。
  • 与对照相比,PCOS女性2型糖尿病的校正风险比(HR)为1.47(95%CI 1.41-1.53)。
  • PCOS的HR在不同BMI分层中保持一致,从肥胖III级亚组的1.37到正常体重亚组的1.78。
  • PCOS队列BMI中位数为34.86 kg/m2,未匹配BMI的无PCOS对照为27.26 kg/m2;与这7.6 kg/m2的BMI差异相关的2型糖尿病额外HR估计为1.87(95%CI 1.82-1.92)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the relationship between polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus (T2DM) in a retrospective US cohort. DESIGN: Longitudinal case-control study. SUBJECTS: The study utilized data from the IBM Explorys database, a comprehensive real-world dataset containing deidentified, longitudinal patient-level electronic health records from approximately 400 hospitals across the United States. The study population consisted of women diagnosed with PCOS between 2000 and 2020, aged 25 to 55 years (n = 42,030) and control women without PCOS (n = 84,060), matched 1:2 by ethnicity, geographic region, age, and body mass index (BMI). Additionally, a secondary control group (n = 42,030) was employed, matched on all covariates except BMI. EXPOSURE: The PCOS status was identified using International Classification of Disease -coded diagnoses, whereas T2DM diagnosis was determined using International Classification of Disease-coded diagnoses as well as hemoglobin A1c levels. MAIN OUTCOME MEASURES: The incidence of T2DM. RESULTS: The 3-year cumulative incidence rates of T2DM in the PCOS and non-PCOS cohorts were 9.2% (95% Confidence Interval: 8.9%-9.5%) and 6.0% (5.8%-6.2%), respectively. The 15-year cumulative incidence rates were 34.3% (31.4%-37.4%) and 22.6% (21.2%-24.1%), respectively. The adjusted hazard ratio (HR) of T2DM in women with PCOS was 1.47 (1.41-1.53) compared with control individuals. The HRs for PCOS were found to be consistent in different BMI strata ranging from 1.37 in the obese class III subgroup to 1.78 in the subgroup with normal weight. The median BMI in the PCOS cohort was 34.86 kg/m2, in contrast to 27.26 kg/m2 in non-PCOS controls not matched for BMI. The additional HR for T2DM associated with this BMI difference of 7.6 kg/m2 is estimated to be 1.87 (1.82-1.92). CONCLUSION: In the current analysis, PCOS was independently associated with increased T2DM incidence across all BMI categories. Moreover, the elevated BMI in patients with PCOS confers additional T2DM risk mediated by excess adiposity. This BMI-mediated risk exceeds the risk associated with PCOS through other mechanisms, such as hyperandrogenism.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Sharafutdinov K, Hilpert J, Burghaus R, et al. Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients. Fertil Steril. 2025. PMID: 40946959. doi:10.1016/j.fertnstert.2025.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。